Showing results (61-70 of 10,695) with videos related to
Sort By:
Pageof 1,070
Journal of the American College of Cardiology|November 1, 1996
Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice?M PackerThe Israel Journal of Psychiatry and Related Sciences|November 6, 1998
Jewish mystical movements and the European ergot epidemicsS PackerThe American Journal of Cardiology|January 3, 1989
Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failureM PackerDiabetes, Obesity & Metabolism|January 10, 2020
Interplay of adenosine monophosphate-activated protein kinase/sirtuin-1 activation and sodium influx inhibition mediates the renal benefits of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: A novel conceptual frameworkMilton PackerJournal of Cardiovascular Electrophysiology|October 19, 2019
Heightened risk of intensive rate control in patients with atrial fibrillation who are obese or have type 2 diabetes: A critical review and re-evaluationMilton PackerJournal of Cardiac Failure|April 19, 2023
The First Dedicated Comprehensive Heart Failure Program in the United States: The Division of Circulatory Physiology at Columbia Presbyterian (1992-2004)Milton PackerEuropean Heart Journal|May 28, 2020
Longevity genes, cardiac ageing, and the pathogenesis of cardiomyopathy: implications for understanding the effects of current and future treatments for heart failureMilton PackerCardiovascular Diabetology|May 15, 2020
Autophagy-dependent and -independent modulation of oxidative and organellar stress in the diabetic heart by glucose-lowering drugsMilton PackerJournal of the American College of Cardiology|June 26, 2024
Lessons for Cardiovascular Clinical Investigators: The Tumultuous 2,500-Year Journey of Physicians Who Ignited Our FireMilton PackerPageof 1,070